Lv31
359 积分 2022-02-15 加入
Olverembatinib (HQP1351): a third-generation tyrosine kinase inhibitor in the treatment of hematologic and solid malignancies—a comprehensive review of clinical outcomes
40分钟前
求助中
Bronchospasme après application cutanée d’une pommade aux huiles essentielles chez un patient asthmatique
12天前
已关闭
Teriflunomide
14天前
已完结
Ocrelizumab/Teriflunomide
14天前
已关闭
Re: Niraparib and Abiraterone Acetate plus Prednisone for HRR-deficient Metastatic Castration-sensitive Prostate Cancer: A Randomized Phase 3 Trial
20天前
已完结
HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
20天前
已关闭
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
20天前
已关闭
Successful Treatment of Evans Syndrome With efgartigimod: A Case Report
27天前
已完结
A Persistent Problem: Mycobacterium abscessus Infection of an Orthopedic Device after Trauma
27天前
已关闭
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
